Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Jesper Gromada
Andrew J. Murphy
Haruka Okamoto
Yang Wei
Samuel Davis
Date of Patent
October 10, 2023
Patent Application Number
17332215
Date Filed
May 27, 2021
Patent Citations
Patent Primary Examiner
Patent abstract
The present invention provides modified glucagon-like peptide 1 (GLP1) polypeptides, fusion proteins comprising modified GLP1 polypeptides, and methods of use thereof. In various embodiments of the invention, the fusion proteins are GLP1 receptor agonists that comprise a modified GLP1 fused to a stabilizing domain. In some embodiments, the fusion proteins comprising modified GLP1 are useful for treating or ameliorating a symptom or indication of a disorder such as obesity and diabetes.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
